KwikPsych

Personality Disorder Evaluation & Medication Management
Personality Disorder Evaluation & Medication Management

Personality Disorder Evaluation & Medication Management

Accurate diagnosis is the foundation of effective treatment. Personality disorders are complex, often presenting with...

Personality Disorders Evaluation & Medication Management

Accurate diagnosis is the foundation of effective treatment. Personality disorders are complex, often presenting with overlapping features, co-occurring mental health conditions, and ambiguous symptom histories. At KwikPsych, we provide comprehensive psychiatric evaluation that leads to precise diagnostic formulation and thoughtful medication management tailored to your specific presentation.


Why Specialized Evaluation Matters

Personality disorders are frequently misdiagnosed because:

Overlap between disorders: Someone with avoidant PD features might initially seem like they have social anxiety disorder. Narcissistic traits appear in histrionic, borderline, and antisocial presentations. The core drivers differ substantially, pointing to different treatment approaches.

Acute vs. chronic: During a depressive episode, someone might seem to have depressive personality features when actually they have BPD with superimposed depression. Accurate assessment requires understanding baseline patterns.

Defensive presentation: People sometimes minimize or hide personality disorder traits. Someone with paranoid PD might present as merely "careful and realistic." Narcissistic traits hide behind false humility. Skilled diagnostic assessment teases out the actual pattern.

Trauma overlap: Trauma creates symptoms that resemble personality disorders (hypervigilance, emotional dysregulation, dissociation, difficulty trusting). Distinguishing whether someone has underlying personality pathology, trauma-driven symptoms, or both requires careful evaluation.

Axis II → Axis I cascade: Personality disorders create vulnerability to episodic disorders. Someone with avoidant PD becomes depressed. Someone with dependent PD develops anxiety. Treating the episodic condition without addressing personality-level drivers often results in recurrence.


Comprehensive Psychiatric Evaluation Process

Phase 1: Detailed History Taking (1-2 hours)

Presenting complaint and current stressors

  • What brings you here?
  • What's been happening that prompted this visit now?
  • What are you hoping will change?

Relationship history (critical for personality assessment)

  • Describe your close relationships across the lifespan
  • How do relationships typically begin and end?
  • Common patterns or conflicts?
  • Current relationship structure and satisfaction
  • How do you navigate disagreements?
  • Do you tend toward emotional intensity or distance?

Work and academic history

  • Performance, satisfaction, conflicts with supervisors/colleagues
  • Frequency of job changes and reasons
  • Ability to focus, follow direction, collaborate

Self-perception and values

  • How do you describe yourself?
  • What are your core strengths and weaknesses?
  • How do you think others see you?
  • What matters most to you?

Emotional functioning

  • Typical mood baseline
  • How intense are your emotions?
  • How quickly do emotions change?
  • Can you recognize emotion early or do they surprise you?
  • How do emotions influence decisions and behavior?

Impulse control and risk behaviors

  • Substance use patterns and triggers
  • Self-harm or suicidal thoughts (frequency, intensity, intention)
  • Risky sexual behavior, spending, driving
  • Aggression or violence

Childhood and family

  • Parenting style (warmth, consistency, boundaries, emotional attunement)
  • Family stability (divorce, loss, illness, moves)
  • Trauma or abuse
  • Parental mental health or substance use
  • Early interpersonal patterns

Past psychiatric treatment

  • Previous diagnoses
  • What treatments helped? What didn't?
  • Medication trials and responses
  • Why treatment ended

Phase 2: Structured Assessment Tools

Dr. Thangada may use validated instruments to systematize assessment:

SCID-5-PD (Structured Clinical Interview for DSM-5 Personality Disorders)

  • Module-by-module assessment of all 10 DSM-5 personality disorders
  • Clinician asks specific diagnostic criteria questions
  • Yields threshold scores for each disorder
  • Gold standard for personality disorder diagnosis
  • Takes 45-90 minutes depending on presentation

MCMI-IV (Millon Clinical Multiaxial Inventory)

  • Self-report questionnaire (175 items)
  • Measures personality traits and clinical syndromes
  • Useful for initial screening and identification of patterns
  • Provides scale profiles comparing to clinical populations

PAI (Personality Assessment Inventory)

  • Self-report (344 items)
  • Measures personality traits and psychopathology
  • Validity scales detect response bias
  • Useful for treatment planning and monitoring progress

PDQ-4+ (Personality Diagnostic Questionnaire)

  • Screening tool (99 items)
  • Quick assessment of personality disorder traits
  • Identifies which specific disorders to investigate further
  • Good for ruling out personality pathology

NEO-PI-R (Revised NEO Personality Inventory)

  • Measures Big Five personality traits (Openness, Conscientiousness, Extraversion, Agreeableness, Neuroticism)
  • Contextualizes personality disorder traits within normal personality variation
  • Useful for understanding strengths and treatment planning

Phase 3: Mental Status Examination

Formal assessment of:

Appearance and behavior

  • Grooming, dress, unusual behaviors
  • Eye contact, body language
  • Agitation, psychomotor retardation

Speech

  • Rate, volume, coherence
  • Pressured vs. slowed
  • Tangentiality, derailment

Mood and affect

  • Self-reported mood
  • Observed emotional expression
  • Appropriateness and range

Thought process and content

  • Organization and logic
  • Presence of delusions, obsessions, preoccupations
  • Suicidal or homicidal ideation
  • Unusual beliefs

Cognition

  • Orientation to person, place, time
  • Memory screening
  • Concentration
  • Abstract thinking

Judgment and insight

  • Understanding of condition
  • Willingness to accept diagnosis
  • Capacity to plan treatment

Diagnostic Formulation: Moving Beyond Labels

A good diagnostic formulation answers several questions:

What is the primary personality disorder diagnosis?

Based on DSM-5 criteria, which specific pattern best fits your presentation?

Are there comorbid personality disorders?

Many people meet criteria for multiple personality disorders. Understanding the combination clarifies treatment direction.

What co-occurring conditions are present?

  • Major depression, bipolar disorder, anxiety disorders
  • PTSD or complex PTSD
  • Substance use disorder
  • ADHD, autism spectrum
  • Medical conditions (thyroid, neurological, chronic pain)

What's the dimensional severity?

How much distress are you experiencing? How much impairment in functioning? This determines treatment intensity.

What vulnerabilities are present?

  • Suicide risk level
  • Substance use vulnerability
  • Victimization or exploitation risk

What are your strengths?

  • Relationships that are stable
  • Work or creative abilities
  • Values and intrinsic motivation
  • Insight and capacity to reflect

What's the likely etiology?

Understanding how the personality disorder developed (genetic loading, trauma, attachment patterns, learned coping) informs treatment.


Dimensional vs. Categorical Assessment

Traditional Categorical Approach

The DSM-5 uses categorical diagnosis: either someone meets criteria for a disorder or they don't. This approach is practical for:

  • Clear communication among providers
  • Insurance and billing
  • Research and outcome measurement
  • Treatment planning

Limitations: Personality pathology exists on a spectrum, not in discrete categories. Someone with 4 of 5 criteria for BPD is qualitatively different from someone with 8 criteria, but both get the same diagnosis.

Dimensional Approach

The Alternative DSM-5 Model (Section III) conceptualizes personality disorders dimensionally:

Impairment in self-functioning:

  • Identity (self-image, stability of goals/values)
  • Self-direction (ability to set and pursue meaningful goals)

Impairment in interpersonal functioning:

  • Empathy (capacity to recognize and understand others' emotions)
  • Intimacy (capacity for close relationships)

Trait domains:

  • Negative affectivity, detachment, antagonism, disinhibition, psychoticism

Each person gets a profile of functioning across these dimensions rather than just a categorical label.

How This Applies to Treatment

Understanding your dimensional profile clarifies what specifically to target:

High negative affectivity? Focus on emotion regulation skills.

High detachment? Work on connection and perspective-taking.

High antagonism? Address empathy development and effects on others.

High disinhibition? Teach distress tolerance and impulse management.

High psychoticism? Reality-test unusual beliefs and manage paranoia.


Medication Management Principles

At KwikPsych, our approach to medication is thoughtful and evidence-informed.

Foundational Principles

Medications don't treat personality disorders, they address symptoms that respond to medication.

This distinction is crucial. Taking medication won't change the core personality patterns. However, reducing co-occurring depression, anxiety, emotional dysregulation, or paranoia can:

  • Make psychotherapy possible
  • Reduce crisis episodes
  • Improve functioning at work and in relationships
  • Decrease suffering

Start low, go slow, and do nothing without reason.

We avoid the common pitfall of escalating medications because someone feels worse. Often, feeling worse means therapy is touching something important, not that medication is needed.

Combine medication with psychotherapy.

Research consistently shows medication alone is insufficient for personality pathology. The combination of targeted medication + specialized therapy produces the best outcomes.

Regular monitoring and adjustment.

We review medication effectiveness and side effects regularly. If something isn't working after 6-8 weeks, we adjust. If it's working, we don't change it.


Symptom-Targeted Pharmacotherapy

Emotional Dysregulation and Mood Instability

First-line: SSRIs

  • Sertraline (Zoloft), fluoxetine (Prozac), paroxetine (Paxil)
  • Evidence for reducing anger and emotional reactivity
  • Typical dose range: 50-200mg daily
  • Takes 4-8 weeks to see full effect

Second-line: Mood Stabilizers

  • Lamotrigine (Lamictal): particularly helpful for BPD-related dysphoria and impulsivity
  • Starting dose 25mg, gradual titration to 200mg+ over weeks
  • Requires slow titration due to rare rash risk
  • No blood monitoring needed
  • May help emotion regulation more than depression directly
  • Valproate (Depakote): for aggressive impulsivity and affective dyscontrol
  • Starting dose 250-500mg daily, titration to 750-1500mg
  • Requires blood monitoring (liver function, drug levels)
  • More side effects than lamotrigine
  • Used when lamotrigine insufficient

Note on antidepressants: Some people with BPD worsen on SSRIs (activation, disinhibition). If this occurs, we adjust or try different classes.

Anger and Aggression

First approach: address underlying dysregulation (above)

Additional options:

  • Low-dose antipsychotics (aripiprazole 2-10mg, risperidone 0.5-4mg) for severe rage
  • Propranolol (40-160mg daily) for physiological aggression symptoms
  • Combination of mood stabilizer + SSRI often more effective than either alone

Anxiety

SSRIs and SNRIs (serotonin-norepinephrine reuptake inhibitors like venlafaxine)

  • First-line for generalized anxiety, social anxiety, panic in personality disorder context
  • Same agents and doses as for mood dysregulation

Buspirone

  • Non-habit-forming anxiolytic
  • Useful adjunct, 15-60mg daily
  • Slower onset than benzodiazepines but safer

Benzodiazepines

  • Used cautiously and briefly due to addiction risk, particularly in Cluster B
  • If needed: short-term, low doses, clear endpoint
  • Never long-term maintenance for personality disorders

Paranoid Ideation and Perceptual Distortions

Low-dose antipsychotics for stress-related paranoia or unusual perceptual experiences

  • Aripiprazole (Abilify): 2-10mg daily
  • Risperidone (Risperdal): 0.5-4mg daily
  • Quetiapine (Seroquel): 50-300mg daily

These address the symptom when it arises, used at lowest effective dose, with regular monitoring.

Sleep Disturbance

Sleep hygiene first: Consistency, cool dark room, no screens before bed, exercise, no caffeine after 2pm

If needed:

  • Trazodone: sedating antidepressant, 50-200mg at bedtime
  • Mirtazapine: antidepressant with sedating properties, 15-30mg at bedtime
  • Melatonin: non-prescription, 3-10mg at bedtime (minimal evidence but safe)
  • Avoid benzodiazepines due to addiction risk

Substance Use Cravings

If concurrent substance use disorder is present:

  • Naltrexone (Vivitrol): opioid antagonist
  • Acamprosate (Campral): for alcohol
  • Bupropion: may reduce cravings, address depression
  • Always combined with psychotherapy and support groups

Medication Monitoring

Initial Phase (First 6-8 weeks)

Baseline labs before starting medication:

  • Liver and kidney function
  • Electrolytes
  • Blood glucose
  • Blood pressure

Follow-up schedule:

  • 1-2 weeks: assess initial tolerability, side effects
  • 4-6 weeks: evaluate therapeutic response
  • 8 weeks: full assessment, adjust if needed

Ongoing Monitoring

Regular appointments:

  • Monthly initially, extending to quarterly once stable
  • Assess effectiveness at each visit
  • Monitor for side effects
  • Evaluate changes in mood, behavior, relationships
  • Adjust doses based on response and tolerability

Annual labs:

  • Repeat baseline labs if on mood stabilizers or antipsychotics
  • Monitor weight, metabolic changes, movement disorders

Safety assessment:

  • Suicidal ideation (particularly after starting antidepressants)
  • Substance use changes
  • New risky behaviors
  • Medication compliance

Special Considerations in Personality Disorders

Substance Use and Addiction Risk

People with Cluster B personality disorders (especially BPD and antisocial PD) have higher substance use risk. We:

  • Avoid long-term benzodiazepines (extremely high addiction risk)
  • Educate about addiction risk
  • Screen for substance use at each visit
  • Refer to addiction specialist if needed
  • Never prescribe stimulants for ADHD without careful assessment

Medication Side Effects and Personality

Some medication side effects interact with personality traits:

Weight gain (with antipsychotics, some antidepressants) may be devastating for someone with narcissistic traits focused on appearance, or trigger eating disorder behaviors in BPD.

Sexual dysfunction (SSRIs) particularly problematic for someone with histrionic PD centered on sexual desirability.

Cognitive blunting (some antipsychotics) difficult for someone with schizoid PD who values detached observation.

We discuss side effects upfront and consider which medications best fit individual values.

Suicidality and Medication

Antidepressants can increase suicidal ideation, particularly in younger adults in the first 1-2 weeks. People with BPD already at high suicide risk need:

  • Clear communication about this risk
  • More frequent early monitoring
  • Concurrent psychotherapy
  • Crisis safety planning

We don't avoid antidepressants due to risk; rather, we monitor carefully.


Creating Your Medication Plan

During the initial evaluation, we discuss:

  1. Specific symptoms to target - Which symptoms cause the most suffering or impairment?
  2. Treatment timeline - When do you hope to see improvement?
  3. Side effect tolerance - Which side effects are deal-breakers?
  4. Lifestyle factors - Caffeine, exercise, sleep that might support medication response
  5. Previous medication experiences - What's worked or not worked before?
  6. Substance use - History and current use affecting medication choices
  7. Pregnancy or nursing - Special medication considerations
  8. Other medications or supplements - Drug interactions to check

Medication Adjustment or Discontinuation

If medication isn't working after 6-8 weeks:

We typically increase dose first, then try different agents in the same class or switch to different classes.

If side effects outweigh benefits:

We discontinue or switch agents.

Once symptoms stabilize:

We discuss whether to continue indefinitely or attempt gradual discontinuation. Many personality disorder medications need to continue to maintain gains.

Discontinuing medication:

Always gradual to avoid withdrawal effects. We don't stop abruptly.


Integration with Psychotherapy

The most effective approach combines:

Medication management targeting:

  • Acute suffering (severe depression, anxiety, dysregulation)
  • Symptoms impeding therapy (paranoia, dissociation, impulsivity)
  • Comorbid conditions (ADHD, depression, bipolar)

Psychotherapy targeting:

  • Core personality patterns
  • Relationship dynamics
  • Emotional and behavioral skills
  • Meaning-making and identity

Dr. Thangada regularly communicates with your therapist about your response to treatment, medication effects, and emerging concerns. This coordination ensures you're receiving integrated care.


Getting Started with Evaluation

What to Bring

  • Insurance card
  • List of current medications and supplements
  • Medical history summary
  • Previous psychiatric or psychological records if available
  • List of questions or concerns

Initial Appointment Overview

  1. Detailed history and current symptoms (45-60 minutes)
  2. Mental status examination (15-20 minutes)
  3. Discussion of diagnostic impressions and treatment options (15-20 minutes)
  4. If medication recommended: detailed discussion of specific agents, expected timeline, side effects, monitoring

Total time: 90-120 minutes

Next Steps

After the evaluation:

  • Written diagnostic summary provided to you and your therapist
  • Medication plan (if recommended) with clear instructions
  • Referral to therapist specializing in personality disorders
  • Follow-up appointment scheduled (1-2 weeks to assess medication response)

Contact KwikPsych

Phone: 737-367-1230

Address: 12335 Hymeadow Dr, Ste 450, Austin, TX 78750

Telehealth: Available across Texas

Insurance: Aetna, BCBS, Cigna, UnitedHealthcare, Superior HealthPlan/Ambetter, Baylor Scott & White, Oscar, First Health Network, Optum, Medicare

Self-pay: $299 initial evaluation / $179 follow-up


Crisis Resources

If you or someone you know is in crisis, call 911 or the Suicide & Crisis Lifeline at 988, or text HOME to 741741 (Crisis Text Line).

We understand that beginning psychiatric evaluation can feel overwhelming, particularly if you're in crisis. Crisis lines are always available while you arrange ongoing care.


This content is for educational purposes and should not replace professional medical evaluation. Medication decisions require assessment by a licensed psychiatrist. Individual responses to medications vary; this content describes general evidence-based approaches.

Insurance & Pricing

We accept most major insurance plans, including:

  • Aetna
  • Blue Cross Blue Shield (BCBS)
  • Cigna
  • UnitedHealthcare
  • Superior HealthPlan / Ambetter
  • Baylor Scott & White
  • Oscar
  • Optum
  • Medicare

Plus others. See full list of accepted insurance plans →

Self-pay: Call us at 737-367-1230 to find out latest rates.

Take the next step

Ready to feel like yourself again?

Book a 60-minute evaluation with a board-certified MD psychiatrist. In-person in Austin or telehealth across Texas.